Purpose: The aim of the study was to compare the results of radiofrequency (RF) thermotherapy and transurethral resection of the prostate (TURP) in patients who required benign prostatic obstruction (BPO) surgery and had storage symptoms. Methods: The results of patients who had undergone TURP and RF thermotherapy procedures between December 2019 and 2022 were compared before and after the procedure. Patients’ International Prostate Symptom Scores, maximum flow rate (Qmax), postvoiding residues, and overactive bladder validated 8 scores (OAB-V8) at 3 and 6 months were analyzed. Results: While the preprocedural OAB-V8 in the RF thermotherapy group was 25.85, this score decreased to 18.12 (P<0.001) at the postprocedural 3rd month and 16.42 (P<0.001) at the postprocedural 6th month. While the preprocedural OAB-V8 score in TURP group was 23.26, it decreased to 20.17 (P<0.001) at the postprocedural 3rd month and 19.84 at the postprocedural 6th month, and there was no significant difference between the 3rd-month and 6th-month values (P=0.328). The proportion of de crease in the OAB-V8 scores was 30% at the 3rd month and 36% at the 6th month in the RF thermotherapy group, whereas it was 13% at the 3rd month and 15% at the 6th month in TURP group. Conclusions It was determined that RF thermotherapy was 2.35 times more effective than TURP on OAB-V8 scores. In addition to its acceptable effect on Qmax, its continued effect on storage symptoms at 6 months may be a significant advantage over the TURP. As a minimally invasive method, RF thermotherapy can be offered as a suitable option for BPO patients with storage symptoms.

Purpose: The aim of the study was to compare the results of radiofrequency (RF) thermotherapy and transurethral resection of the prostate (TURP) in patients who required benign prostatic obstruction (BPO) surgery and had storage symptoms. Methods: The results of patients who had undergone TURP and RF thermotherapy procedures between December 2019 and 2022 were compared before and after the procedure. Patients’ International Prostate Symptom Scores, maximum flow rate (Qmax), postvoiding residues, and overactive bladder validated 8 scores (OAB-V8) at 3 and 6 months were analyzed. Results: While the preprocedural OAB-V8 in the RF thermotherapy group was 25.85, this score decreased to 18.12 (P<0.001) at the postprocedural 3rd month and 16.42 (P<0.001) at the postprocedural 6th month. While the preprocedural OAB-V8 score in TURP group was 23.26, it decreased to 20.17 (P<0.001) at the postprocedural 3rd month and 19.84 at the postprocedural 6th month, and there was no significant difference between the 3rd-month and 6th-month values (P=0.328). The proportion of de crease in the OAB-V8 scores was 30% at the 3rd month and 36% at the 6th month in the RF thermotherapy group, whereas it was 13% at the 3rd month and 15% at the 6th month in TURP group. Conclusions It was determined that RF thermotherapy was 2.35 times more effective than TURP on OAB-V8 scores. In addition to its acceptable effect on Qmax, its continued effect on storage symptoms at 6 months may be a significant advantage over the TURP. As a minimally invasive method, RF thermotherapy can be offered as a suitable option for BPO patients with storage symptoms.

Purpose: The aim of the study was to compare the results of radiofrequency (RF) thermotherapy and transurethral resection of the prostate (TURP) in patients who required benign prostatic obstruction (BPO) surgery and had storage symptoms. Methods: The results of patients who had undergone TURP and RF thermotherapy procedures between December 2019 and 2022 were compared before and after the procedure. Patients’ International Prostate Symptom Scores, maximum flow rate (Qmax), postvoiding residues, and overactive bladder validated 8 scores (OAB-V8) at 3 and 6 months were analyzed. Results: While the preprocedural OAB-V8 in the RF thermotherapy group was 25.85, this score decreased to 18.12 (P<0.001) at the postprocedural 3rd month and 16.42 (P<0.001) at the postprocedural 6th month. While the preprocedural OAB-V8 score in TURP group was 23.26, it decreased to 20.17 (P<0.001) at the postprocedural 3rd month and 19.84 at the postprocedural 6th month, and there was no significant difference between the 3rd-month and 6th-month values (P=0.328). The proportion of de crease in the OAB-V8 scores was 30% at the 3rd month and 36% at the 6th month in the RF thermotherapy group, whereas it was 13% at the 3rd month and 15% at the 6th month in TURP group. Conclusions It was determined that RF thermotherapy was 2.35 times more effective than TURP on OAB-V8 scores. In addition to its acceptable effect on Qmax, its continued effect on storage symptoms at 6 months may be a significant advantage over the TURP. As a minimally invasive method, RF thermotherapy can be offered as a suitable option for BPO patients with storage symptoms.

Objective: To evaluate the effect of free and liposome form of gallic acid on bone regeneration in critical defects in Wistar rats. Methods: Thirty-two female Wistar rats were divided into four study groups: group 1, negative control; group 2, positive control; group 3, gallic acid powder; group 4, gallic acid liposome. A critical-sized defect was created in all rats. Groups 2 to 4 had xenograft, autograft and membrane placement while negative control rats did not receive any treatment. The defect area was sutured and rats were kept alive for 30 d. At the end of the study, a bone specimen including the defect area was removed from calvaría. All specimens were evaluated under the stereomicroscope, then underwent histological analysis. Inflammatory cell counts, osteoblast, osteoclast counts, receptor activator of nuclear factor κ-B (RANKL), osteoprotegerin (OPG), runt-related transcription factor 2 (Runx2), bone morphogenetic protein-2 (BMP-2), and alkaline phosphatase were determined. Results: The biggest unhealed defect area was observed in the negative control group and the smallest was observed in the gallic acid liposome group. There were no differences between the positive control group vs. the gallic acid powder group and the gallic acid powder group vs. the gallic acid liposome group. The severity of inflammation was the highest in the negative control group and the lowest in the gallic acid liposome group with significant differences between the groups. All groups had similar osteoblast counts while osteoclast counts were the highest in the positive control group. Gallic acid groups had a lower number of osteoclasts compared with the positive control group. Runx2 and alkaline phosphatase levels were similar in the groups while OPG and BMP-2 levels exhibited a significant increase compared with the negative control group and the positive control group. RANKL was similar in the negative control group, the positive control group, and the gallic acid powder groups but decreased in the gallic acid liposome group. Conclusions: Gallic acid powder and liposome significantly improve bone regeneration in Wistar rats with calvarial defects. The improvement in healing is evident with decreased inflammation and RANKL expressions and increased OPG and BMP-2 expressions. Altan Ahmet 1 Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Gaziosmanpaşa University, Tokat Yuce Hatice 2 Department of Periodontology, Faculty of Dentistry, Gaziosmanpaşa University, Tokat Karataş Őzkan 3 Department of Periodontology, Faculty of Dentistry, Gaziosmanpaşa University, Tokat Taşkan Mehmet 4 Department of Periodontology, Faculty of Dentistry, Gaziosmanpaşa University, Tokat Gevrek Fikret 5 Department of Histology and Embryology, Faculty of Medicine, Gaziosmanpaşa University, Tokat Çolak Sefa 6 Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Gaziosmanpaşa University, Tokat Akbulut Nihat 7 Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Gaziosmanpaşa University, Tokat Al Anouti F, Taha Z, Shamim S, Khalaf K, Al Kaabi L, Alsafar H. An insight into the paradigms of osteoporosis: From genetics to biomechanics. Bone Rep 2019; 11:100216. Doi: 10.1016/j.bonr.2019.100216. Croes M, van der Wal BC, Vogely HC. Impact of bacterial infections on osteogenesis: Evidence from in vivo studies. J Orthop Res 2019; 37(10): 2067-2076. Prideaux M, Findlay DM, Atkins GJ. Osteocytes: The master cells in bone remodeling. Curr Opin Pharmacol 2016; 28: 24-30. Buckley CD, Gilroy DW, Serhan CN. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity 2014; 40(3): 315-327. Toker H, Balci Yuce H, Lektemur Alpan A, Gevrek F, Elmastas M. Morphometric and histopathological evaluation of the effect of grape seed proanthocyanidin on alveolar bone loss in experimental diabetes and periodontitis. J Periodontal Res 2018; 53(3): 478-486. Garlet G, Giannobile W. Macrophages: The bridge between inflammation resolution and tissue repair? J Dent Res 2018; 97(10): 1079-1081. Cheng Y, Li X, Tse HF, Rong J. Gallic acid-l-leucine conjugate protects mice against LPS-induced inflammation and sepsis via correcting proinflammatory lipid mediator profiles and oxidative stress. Oxid Med Cell Longev 2018; 1081287. Doi: 10.1155/2018/1081287. Harikrishnan H, Jantan I, Haque MA, Kumolosasi E. Anti-inflammatory effects of Phyllanthus amarus Schum. & Thonn. through inhibition of NF-kB, MAPK, and PI3K-Akt signaling pathways in LPS-induced human macrophages. BMC Complement Altern Med 2018; 18(1): 224. Doi: 10.1186/s12906-018-2289-3. Albouchi F, Avola R, Dico G, Calabrese V, Graziano ACE, Abderrabba M, et al. Melaleuca styphelioides Sm. polyphenols modulate interferon gamma/histamine-induced inflammation in human NCTC 2544 keratinocytes. Molecules 2018; 23(10): 2526. Doi: 10.3390/molecules23102526. Tominari T, Ichimaru R, Yoshinouchi S, Matsumoto C, Watanabe K, Hirata M, et al. Effects of O-methylated (-)-epigallocatechin gallate (EGCG) on LPS-induced osteoclastogenesis, bone resorption, and alveolar bone loss in mice. FEBS Open Bio 2017; 7(12): 1972-1981. Nicolin V, De Tommasi N, Nori SL, Costantinides F, Berton F, Di Lenarda R. Modulatory effects of plant polyphenols on bone remodeling: A prospective view from the bench to bedside. Front Endocrinol 2019; 10: 494. Doi: 10.3389/fendo.2019.00494. Chauhan S, Sharma A, Upadhyay NK, Singh G, Lal UR, Goyal R. In-vitro osteoblast proliferation and in-vivo anti-osteoporotic activity of Bombax ceiba with quantification of lupeol, gallic acid and β-sitosterol by HPTLC and HPLC. BMC Complement Altern Med 2018; 18(1): 233. Doi: 10.1186/s12906-018-2299-1. Jin P, Liao L, Lin X, Guo Q, Lin C, Wu H, et al. Stimulating effect of a novel synthesized sulfonamido-based gallate ZXHA-TC on primary osteoblasts. Yonssei Med J 2015; 56(3): 760-771. Baek JM, Kim JY, Lee CH, Yoon KH, Lee MS. Methyl gallate inhibits osteoclast formation and function by suppressing Akt and Btk-PLCy 2-Ca2+ signaling and prevents lipopolysaccharide-induced bone loss. Int J Mol Sci 2017; 18(3): 581. Doi: 10.3390/ijms18030581. Posthauer ME, Dorner B, Collins N. Nutrition: A critical component of wound healing. Adv Skin Wound Care 2010; 23(12): 560-572. Vitonyte J, Manca ML, Caddeo C, Valenti D, Peris JE, Usach I, et al. Bifunctional viscous nanovesicles co-loaded with resveratrol and gallic acid for skin protection against microbial and oxidative injuries. Eur J Pharm Biopharm 2017; 114: 278-287. Song HH, Gong X, Williams GR, Quan J, Nie HL, Zhu LM, et al. Self-assembled magnetic liposomes from electrospun fibers. Mater Res Bull 2014; 53: 280-289. Fritze A, Hens F, Kimpfler A, Schubert R, Peschka-Süss R. Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient. Biochim Biophys Acta 2006; 1758(10): 1633-1640. Balci Yuce H, Akbulut N, Ocakli S, Kayir O, Elmastas M. The effect of commercial conjugated linoleic acid products on experimental periodontitis and diabetes mellitus in Wistar rats. Acta Odontol Scand 2017; 75(1): 21-29. Balci Yuce H, Karatas Ö, Tulu F, Altan A, Gevrek F. Effect of diabetes on collagen metabolism and hypoxia in human gingival tissue: A stereological, histopathological, and immunohistochemical study. Biotech Histochem 2018; 94(1): 65-73. Balci Yuce H, Lektemur Alpan A, Gevrek F, Toker H. Investigation of the effect of astaxanthin on alveolar bone loss in experimental periodontitis. J Periodontal Res 2018; 53(1): 131-138. Lee HP, Lin DJ, Yeh ML. Phenolic modified ceramic coating on biodegradable Mg alloy: The improved corrosion resistance and osteoblast-like cell activity. Materials 2017; 10(7): 696. Doi: 10.3390/ma10070696 Huang L, Jin P, Lin X, Lin C, Zheng L, Zhao J. Beneficial effects of sulfonamide-based gallates on osteoblasts in vitro. Mol Med Rep 2017; 15(3): 1149-1156. Hou W, Ye C, Chen M, Li W, Gao X, He R, et al. Belgenin activates SIRT1 as a novel therapeutic agent for osteogenesis of bone mesenchymal stem cells. Front Pharmacol 2019; 10: 618. Doi: 10.3389/fphar.2019.00618. Shim KS, Ha H, Kim T, Lee CJ, Ma JY. Orostachys japonicus suppresses osteoclast differentiation by inhibiting NFATc1 expression. Am J Chin Med 2015; 43(5): 1013-1030. Shim KS, Kim T, Ha H, Lee CJ, Lee B, Kim HS, et al. Water extract of Magnolia officinalis cortex inhibits osteoclastogenesis and bone resorption by downregulation of nuclear factor of activated T cells cytoplasmic 1. Integr Med Res 2015; 4(2): 102-111. Oka Y, Iwai S, Amano H, Irie Y, Yatomi K, Ryu K, et al. Tea polyphenols inhibit rat osteoclast formation and differentiation. J Pharmacol Sci 2012; 118(1): 55-64. Lu Q, Lu PM, Piao JH, Xu XL, Chen J, Zhu L, et al. Preparation and physicochemical characteristics of an allicin nanoliposome and its release behavior. LWT-Food Sci Technol 2014; 57(2): 686-695. Rong Y, Cao B, Liu B, Li W, Chen Y, Liu Y, et al. A novel gallic acid derivative attenuates BLM-induced pulmonary fibrosis in mice. Int Immunopharmacol 2018; 64: 183-191. Alves Barros AS, Oliveira Carvalho H, Dos Santos IVF, Taglialegna T, Dos Santos Sampaio TI, Duarte JL, et al. Study of the non-clinical healing activities of the extract and gel of Portulaca pilosa L. in skin wounds in wistar rats: A preliminary study. Biomed Pharmacother 2017; 96: 182-190. Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. Liposome: Classification, preparation, and applications. Nanoscale Res Lett 2013; 8(1): 102. Doi: 10.1186/1556-276X-8-102.